One Clinical Research

Futó vizsgálatok

• Toboroz

  Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07562152· 3. fázis· Forrás

• Toboroz

  A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

  NCT07469891· 1. fázis· Forrás

• Toboroz

  A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors

  NCT07147348· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

  NCT05609370· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

  NCT05170204· 3. fázis· Forrás

• Toboroz

  Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

  NCT05533697· 1/2. fázis· Forrás

• Toboroz

  A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT05254743· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Rusfertide in Adults With Polycythemia Vera (PV)

  NCT05210790· 3. fázis· Forrás

• Toboroz

  A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  NCT04895709· 1/2. fázis· Forrás

• Toboroz

  A Study of BGB-11417 in Participants With Myeloid Malignancies

  NCT04771130· 1/2. fázis· Forrás

• Fut, nem toboroz

  Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

  NCT04562389· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Hasnyálmirigyrák2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Fej-nyaki daganatok1 toboroz
• Gyermekkori daganatok1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hólyagrák1 toboroz
• Méhnyakrák1 toboroz
• Melanóma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Petefészekrák1 toboroz
• Tripla negatív emlőrák1 toboroz
• Tüdőrák1 toboroz
• Vastagbélrák1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

  NCT05929066· 3. fázis· Forrás

• Lezárult

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· 3. fázis· Forrás

• Lezárult

  A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

  NCT05635708· 2. fázis· Forrás

• Lezárult

  A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

  NCT05309421· 2. fázis· Forrás

• Lezárult

  A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma

  NCT05419388· 2. fázis· Forrás

• Lezárult

  Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

  NCT04370704· 1/2. fázis· Forrás